Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Neurochemistry|August 10, 2017
The medial habenula and interpeduncular nucleus circuitry is critical in addiction, anxiety, and mood regulationIan McLaughlin, John A Dani, Mariella De BiasiCurrent Topics in Behavioral Neurosciences|February 2, 2015
Nicotine withdrawalIan McLaughlin, John A Dani, Mariella De BiasiAmerican Journal of Public Health|August 15, 2014
Reducing tobacco use and access through strengthened minimum price lawsIan McLaughlin, Anne Pearson, Elisa Laird-Metke, et al.Tobacco Control|March 3, 2016
Tobacco industry responsibility for butts: a Model Tobacco Waste ActClifton Curtis, Thomas E Novotny, Kelley Lee, et al.Neuropharmacology|April 28, 2023
CHRNA5 gene variation affects the response of VTA dopaminergic neurons during chronic nicotine exposure and withdrawalKechun Yang, Ian McLaughlin, Jessica K Shaw, et al.HLA|August 5, 2021
MR1 encompasses at least six allele groups with coding region alterationsErik Rozemuller, Sidonia Barbara Guiomar Eckle, Ian McLaughlin, et al.The British Journal of Oral & Maxillofacial Surgery|March 25, 2022
Sentinel lymph node biopsy for early oral cancer - accuracy and considerations in patient selectionDrazsen Vuity, Jeremy McMahon, Stuart Hislop, et al.Vaccine|October 9, 2025
Enhancing vaccine immunogenicity through heterologous prime-boost regimen with multiple nasal boosting with liposomal TLR7 ligandTomoko Hayashi, Shiyin Yao, Fumi Sato-Kaneko, et al.Vaccine|January 9, 2026
A novel calcium influx inducer and a TLR7 agonist are synergistic co-adjuvants that enhance cross-reactive immunity against influenza in young and aged miceYumi Yokoyama, Shiyin Yao, Renna Cozza, et al.Frontiers in Immunology|March 5, 2026
Application of a small molecule calcium influx inducer as a vaccine adjuvant: enhancing Th2-biased immune responsesYumi Yokoyama, Yukiya Sako, Shiyin Yao, et al.Pageof 2